Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
108
Frequently Asked Questions
What is Market Cap of Pharvaris NV?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pharvaris NV market cap is $1.53B.
What is the 52-week high for Pharvaris NV?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pharvaris NV 52 week high is $26.33 as of September 17, 2025.
What is the 52-week low for Pharvaris NV?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pharvaris NV 52 week low is $11.51 as of September 17, 2025.
What is Pharvaris NV stock price today?
Pharvaris NV stock price today is $24.08.
What was Pharvaris NV stock price yesterday?
Pharvaris NV stock price yesterday was $23.81.
What is the PE ratio of Pharvaris NV?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Pharvaris NV’s P/E ratio is -7.07.
What is the Price-to-Book ratio of Pharvaris NV?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Pharvaris NV P/B ratio is 6.0231.
What is the 50-day moving average of Pharvaris NV?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Pharvaris NV 50-day moving average is $22.03.
